Healthcare after the U.S. Midterms: What matters, what doesn't, and what's next?
The U.S. midterm elections will attract significant attention across global markets, but what do they actually mean for the healthcare sector?
On 5 November, DNB invites clients and industry participants to a timely discussion with Andreas Dirnagl, Senior Advisor and global healthcare strategist at DNB. Drawing on extensive experience from the global healthcare sector, Andreas will explore the political, regulatory and market developments most likely to influence healthcare and life sciences in the years ahead.
The session will provide perspectives on topics including drug pricing, FDA policy, healthcare reform, biotech financing and capital markets, while separating political headlines from developments that may have lasting business implications.
The event is particularly relevant for healthcare and life sciences companies, investors and other stakeholders seeking a practical, non-partisan view of the world's most influential healthcare market.
Date: Thursday 5 November 2026
Time: 15:00 –16:00
Location: DNB Carnegie, Overgaden Neden Vandet 9B, 1414 Copenhagen K
Registration is required no later than 28 October 2026